Hematology Articles

• Daunorubicin for Younger Adults With Acute Myeloid Leukemia Daunorubicin dose intensification has benefits in select patients with acute myeloid leukemia.
  Journal Watch, November 2009
• Assessment of the Neck and Lymph Nodes in the Elderly Patient Next in this important series on geriatric assessment: examining the neck and lymph nodes.
  Medscape Family Medicine, November 2009
• Video Day in Review from AHA 2009 with Dr. Melissa Walton-Shirley: Monday, November 16   Join Dr. Walton-Shirley for a review of ARBITER 6-HALTS, Primary PCI in Massachusetts, high ionizing radiation, soybeans and omega-3 fatty acid, video games, anemia and transfusion, and darbepoetin alfa.
  Medscape Cardiology, November 2009
• Plasma HIV RNA is a Risk Factor for Non-Hodgkin's Lymphoma John G. Bartlett, MD, comments on this observational study that establishes viral load as a risk factor for non-Hodgkin's lymphoma in people living with HIV/AIDS.
  Medscape HIV/AIDS, November 2009
• Sonic Hedgehog Signaling Proteins and ATP-Binding Cassette G2 Are Aberrantly Expressed in Diffuse Large B-Cell Lymphoma How does the expression of sonic hedgehog signaling proteins compare among diffuse large B-cell lymphoma, follicular lymphoma, and chronic lymphocytic leukemia?
  Modern Pathology, November 2009
• Association of Genetic Polymorphisms With Interferon-Induced Haematologic Adverse Effects in Chronic Hepatitis C Patients Investigators sought to identify host genetic polymorphisms associated with the efficacy or hematologic toxicity of IFN-based combination therapy in chronic hepatitis C patients.
  Journal of Viral Hepatitis, October 2009
• Outcomes of Patients With Burkitt Lymphoma Older Than Age 40 Treated With Intensive Chemotherapeutic Regimens This study takes a look at an underrepresented group of patients with Burkitt lymphoma who are treated with intensive chemotherapy: those older than age 40 years.
  Clinical Lymphoma & Myeloma, October 2009
• Evaluating the Patient With Abnormal Liver Tests Don't miss this practical advice for evaluating patients presenting with signs and symptoms of a liver disorder.
  Medscape Gastroenterology, October 2009
• Reversibility of Renal Impairment in Patients With Multiple Myeloma Treated With Bortezomib-Based Regimens: Identification of Predictive Factors Investigators sought to evaluate the impact of bortezomib on the improvement of renal function in patients with multiple myeloma and to identify predictive factors associated with renal response.
  Clinical Lymphoma & Myeloma, October 2009
• The Safety Profile of Anti-Tumour Necrosis Factor Therapy in Inflammatory Bowel Disease in Clinical Practice: Analysis of 620 Patient-Years Follow-up Investigators reviewed the safety profile of anti-TNF agents in all patients with Crohn disease, ulcerative colitis, and celiac disease treated with infliximab in Edinburgh from 1999 to 2007.
  Alimentary Pharmacology & Therapeutics, October 2009
• Emerging Therapies for B-Cell Non-Hodgkin Lymphoma This article discusses novel therapies that are being developed for the treatment of B-cell non-Hodgkin lymphoma.
  Expert Review of Anticancer Therapy, September 2009
• Dose-Dense Paclitaxel and Carboplatin in Ovarian Cancer   A weekly regimen provided longer progression-free survival and overall survival than standard treatment in patients with ovarian cancer. Dr. Maurie Markman summarizes the Sept. 20 Lancet article.
  Medscape Hematology-Oncology, September 2009
• Transplantation for Non-Hodgkin Lymphoma Investigators assessed the outcomes of auto-hematopoietic stem cell transplantation (HCT) and allo-HCT for various lymphomas, particulary non-Hodgkin lymphoma.
  Expert Review of Hematology, September 2009
• Utility of CD56 Immunohistochemical Studies in Follow-up of Plasma Cell Myeloma What is the potential role of CD56 immunohistochemical analysis in monitoring residual plasma cell myeloma?
  American Journal of Clinical Pathology, September 2009
• Pathogenesis and Management of Myeloma Bone Disease This article reviews recent advances in understanding the biology of bone disease in multiple myeloma, its diagnosis, and recent progress in treatment options.
  Expert Review of Hematology, August 2009
• Pseudoxanthoma Elasticum-like Syndrome and Thalassemia: An Update This article describes three cases of Pseudoxanthoma elasticum, a rare inherited connective tissue disorder.
  Dermatology Online Journal, July 2009
• Hodgkin Lymphoma With Cutaneous Involvement The case of 54-year-old man presenting with a single cutaneous ulcer, subsequently diagnosed with Hodgkins Lymphoma.
  Dermatology Online Journal, May 2009
• Flow Cytometry Can Diagnose Classical Hodgkin Lymphoma in Lymph Nodes With High Sensitivity and Specificity Hodgkin lymphoma diagnosis has historically been made in tissue sections, since flow cytometry has been unsuccessful. How has this changed?
  American Journal of Clinical Pathology, March 2009
• Waxing and Waning Pulmonary Nodules and Myelodysplastic Syndrome A 53-year-old diabetic woman with the diagnosis of myelodysplastic syndrome was admitted to hospital with symptoms of anorexia, malaise, fatigue, night sweats, and weight loss.
  Southern Medical Journal, July 2009
• Can Erythropoiesis-Stimulating Agents Increase Mortality in Patients With Cancer? Commentary on a study on the effect of erythropoiesis-stimulating drugs on mortality in patients with cancer, published May 2009 in The Lancet.
  Medscape General Surgery, August 2009